In this work, a large excess of electrostatic repulsion, arising from the axial ligands, over that from the equatorial ligands is taken as the design strategy for high performance pentagonal bipyramidal (PBP) DyIII single-ion magnets (SIMs).
It is crucial to promote axiality to enhance easy-axis magnetic anisotropy. Two mononuclear Dy compounds, in which each Dy is nine-coordinated, namely, [(CHNO)Dy(NO)(HO)]·CHOH (1) and [(CHNO)Dy(NO)(CHOH)]·HO (2) (HL = N-(2-pyridoyl)-4-pyridinecarboxamidrazone), have been prepared through controlling the amount of CHOH and HO solvents. Geometry modulations were realized by interchanging coordinated and lattice solvents, thus achieving a structure closer to the configuration of a capped square antiprism for 2 compared to that for 1. Notably, magnetic studies revealed that compound 1 displays no slow relaxation of magnetization while compound 2 exhibits single-molecule magnet (SMM) behaviour in the absence of a static magnetic field, with the highest energy barrier (203.11 K) of nine-coordinated Dy SMMs. Ab initio calculations were performed to elucidate such a distinct performance, demonstrating that the combination of the larger charge distribution along the magnetic axis and the lower charge distribution in the equatorial plane generates a strong easy-axis ligand field to enhance magnetic properties, which is further associated with the structural symmetry. In addition, a possible coordination mode is proposed to realize high axis anisotropy for nine-coordinated Dy compounds. This work presents an effective method to modulate the dynamic magnetic relaxation of the Dy SMMs through interchange between coordinated and lattice solvents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.